Manganese compounds
Manganese compounds at Waupaca Foundry-Plant 5 have more than three-quarters since 2010 (through 2024).
TRI facility · TRI 2024 reporting year
Waupaca Foundry-Plant 5
Total reported releases 2.4M lb held roughly steady year over year (-4%). Total releases concentrations have fallen 40% since 2010.
9856 STATE HWY 66, Tell City, Indiana · 331511 · Primary Metals · operated by Monomoy Capital Partners LLC
Anomaly engine
Notable Signals
Lead compounds
Lead compounds at Waupaca Foundry-Plant 5 have more than halved since 2010 (through 2024).
Chemicals reported · most recent year
What This Facility Releases
Zinc compounds
Zinc compounds concentrations are up 33% since 2010.
Manganese compounds
Manganese compounds concentrations have more than halved since 2010.
Toluene
Toluene concentrations are roughly unchanged from 2010.
Benzene
Benzene concentrations are roughly unchanged from 2010.
Lead compounds
Lead compounds concentrations have more than halved since 2010.
Copper compounds
Copper compounds concentrations are roughly unchanged from 2010.
Xylene (mixed isomers)
Xylene (mixed isomers) concentrations are roughly unchanged from 2010.
Methanol
Methanol concentrations are up 59% since 2014.
Equity context · ACS 2018-2022 block-group demographics
Who Lives Next To This Facility
Within 3 miles of this facility (6 Census block groups, population-weighted demographics): a population of 6,163. Why we surface this →
35.4%
Low-income
7.6%
People of color
6.1%
Under age 5
20.2%
Over age 64
Source: Census ACS 2018-2022 block-group demographics, population-weighted across the 3-mile buffer around this facility (from USEPA-clone/EJAM-open blockgroupstats). Indicator-level percentile and EJ-disparity scores are surfaced on the county page and the state page — they describe wider regional exposure burdens, not effects attributable to a single facility.
Source. EPA Toxics Release Inventory · retrieved 2026-05-07. Reporting year 2024. TRI is a federal public-domain dataset under 17 USC §105.
What this is not. TRI quantifies releases reported by the facility under EPCRA §313 — not ambient air or water concentrations measured at receptors. We do not attribute individual health outcomes to specific facilities; that exceeds what the data can support.